
Wooju Jeong
@urojeong
senior staff Urologist at Henry Ford Health System, Vattikuti Urology Institute
ID: 2479858263
12-04-2014 21:30:43
260 Tweet
196 Followers
239 Following

Today at #AUA19 Sohrab Arora will present the work from VCORE on Inpatient morbidity and cost of cytoreductive radical prostatectomy 11:20 AM MCP: W185d Firas Abdollah Akshay Sood Deepansh Dalela jamesopeabody Mani Menon #UroSoMe

Lunch sponsored by jamesopeabody at Sociale Dan Pucheril Akshay Sood Sohrab Arora @LindaCHsu


In two hours, Sohrab Arora will be presenting the work from VCORE and Vattikuti Foundation on the feasibility of omitting outer cortical layer of renorrhaphy during robotic partial nephrectomy. Firas Abdollah Craig Rogers MD Mani Menon Wooju Jeong Alex Mottrie Mahendra bhandari #AUA19


Privileged to present this work by 41 surgeons at 14 centers in 9 countries. #AUA19 #VCQI Firas Abdollah

Mani Menon talks to a full house about precision prostatectomy Firas Abdollah jamesopeabody Wooju Jeong Dan Pucheril Craig Rogers MD Quoc-Dien Trinh, MD, MBA Sohrab Arora


In an hour, Lee Baumgarten will be presenting his work on the timing of radiation therapy on adverse events following Radical prostatectomy: a post hoc analysis of the RTOG 9601 trial. Firas Abdollah Akshay Sood Sohrab Arora jamesopeabody Mani Menon Craig Rogers MD #Aua19


#AUA19 Mani Menon presenting the initial results of Menon precision prostatectomy at SURS meting (the SAAD trial: Sood, Arora, Abdollah, Dalela) Akshay Sood Sohrab Arora Firas Abdollah Deepansh Dalela


In an hour, our medical student Nikola Rakic will be presenting on the persistent under utilization of adjuvant Radiotherapy in patients with adverse pathological features at Radical prostatectomy. Firas Abdollah Akshay Sood Sohrab Arora Mani Menon Craig Rogers MD jamesopeabody #AUA19


In an hour, Firas Abdollah will present on evaluation of the impact of lead time bias in the efficacy of salvage Radiotherapy in prostate cancer: analysis of RTOG 9601 Trial. #AUA19


Nikola Rakic, our medical student talking about the work from VCORE on underutilization of adjuvant Radiotherapy in patients with adverse pathological features at Radical prostatectomy. #AUA19 Firas Abdollah Sohrab Arora Akshay Sood jamesopeabody Mani Menon Craig Rogers MD

Lee Baumgarten talking about the work from VCORE on impact of timing on radiation therapy adverse events following Radical prostatectomy Firas Abdollah Sohrab Arora jamesopeabody Mani Menon Craig Rogers MD Akshay Sood #AUA19

Radiation cystitis: A question with no answers? (and no funding for research) In two hours, Sohrab Arora will be presenting on admission rates, healthcare utilization, and economic burden of radiation cystitis in the United States. #AUA19 Firas Abdollah Craig Rogers MD Mani Menon


#AUA19 Firas Abdollah Is presenting on the evaluation of the impact of lead time bias in the efficacy of salvage Radiotherapy in prostate cancer: analysis of RTOG 9601 Trial. Craig Rogers MD Mani Menon jamesopeabody Akshay Sood Sohrab Arora


A question with no answers? Radiation cystitis: healthcare utilization and economic burden. Sohrab Arora will be presenting this work from VCORE in half an hour from now Firas Abdollah Craig Rogers MD Mani Menon jamesopeabody


#AUA19 Firas Abdollah received the best reviewer award from Journal of Urology Amer. Urol. Assn. #VCORE Congratulations, Dr. Abdollah!


Congratulations to the Vattikutti Urology Institute team for a successful #AUA19 with 25 presentations!! Craig Rogers MD Mani Menon jamesopeabody Firas Abdollah Salanee Akshay Sood Sohrab Arora Lee Baumgarten, MD Audrey Fotouhi Kristina Suson, Mustafa, Nikola, Akpatelurol, Philip, Roumayah.

. Ravi Barod, our former fellow, is here at Vattikutti Urology Institute, talking about the establishment of a high-volume kidney cancer program in the UK. Great work, Dr. Barod! Craig Rogers MD Mani Menon jamesopeabody



thank you so much for having me!... it was my pleasure talking about what I learnt from the pioneers of #roboticsurgery Mohammed Israil and how we are translating that for our kidney cancer patients Royal Free London
